Kaskela Law LLC has commenced an investigation on behalf of Medallia, Inc. (NYSE: MDLA) (“Medallia” or the “Company”) stockholders in connection with the recently announced sale of the Company to Thoma Bravo.
On July 26, 2021, Medallia announced that it had entered into an agreement to be acquired by private equity firm Thoma Bravo at a price of $34.00 per share in cash. Notably, shares of Medallia’s common stock traded above $45.00 per share as recently as February 2021. Following the closing of the proposed transaction, shares of Medallia’s stock will no longer be publicly traded.
The investigation is focused on whether Medallia’s board of directors failed to satisfy its fiduciary duties to MDLA stockholders in connection with the sale of the Company, including whether the board obtained the best possible price for shares of Medallia’s stock.
Medallia stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (888) 715 – 1740, or by completing the information form on this page, to discuss this investigation and their legal rights and options.